The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies

被引:95
作者
Barker, Timothy H. [1 ,2 ]
Habibi, Nahal [1 ]
Aromataris, Edoardo [1 ]
Stone, Jennifer C. [1 ]
Leonardi-Bee, Jo [3 ]
Sears, Kim [4 ]
Hasanoff, Sabira [2 ]
Klugar, Miloslav [5 ,6 ]
Tufanaru, Catalin [7 ]
Moola, Sandeep [8 ]
Munn, Zachary [1 ,2 ]
机构
[1] Univ Adelaide, Fac Hlth & Med Sci, JBI, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Publ Hlth, Hlth Evidence Synth Recommendat & Impact HESRI, Adelaide, SA, Australia
[3] Univ Nottingham, Nottingham Ctr Evidence Based Healthcare, JBI Ctr Excellence, Sch Med, Nottingham, England
[4] Queens Univ, Queens Collaborat Hlth Care Qual, Kingston, ON, Canada
[5] Czech GRADE Network, Inst Hlth Informat & Stat Czech Republ, Czech Republic JBI Ctr Excellence, Cochrane Czech Republ, Prague, Czech Republic
[6] Palacky Univ Olomouc, Fac Educ, Ctr Evidence Based Educ & Arts Therapies, JBI Affiliated Grp, Olomouc, Czech Republic
[7] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, Australia
[8] Sanofi Healthcare India Pvt Ltd, Hlth Econ & Value Assessment, Chennai, India
基金
英国医学研究理事会;
关键词
critical appraisal; internal validity; methodological quality; quasi-experimental studies; risk of bias;
D O I
10.11124/JBIES-23-00268
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Systematic reviews of effectiveness offer a rigorous synthesis of the best evidence available regarding the effects of interventions or treatments. Randomized controlled trials are considered the optimal study design for evaluating the effectiveness of interventions and are the ideal study design for inclusion in a systematic review of effectiveness. In the absence of randomized controlled trials, quasi-experimental studies may be relied on to provide information on treatment or intervention effectiveness. However, such studies are subject to unique considerations regarding their internal validity and, consequently, the assessment of the risk of bias of these studies needs to consider these features of design and conduct. The JBI Effectiveness Methodology Group has recently commenced updating the suite of JBI critical appraisal tools for quantitative study designs to align with the latest advancements in risk of bias assessment. This paper presents the revised critical appraisal tool for risk of bias assessment of quasi-experimental studies; offers practical guidance for its use; provides examples for interpreting the results of risk of bias assessment; and discusses major changes from the previous version, along with the justifications for those changes.
引用
收藏
页码:378 / 388
页数:11
相关论文
共 17 条
  • [1] Understanding randomised controlled trials
    Akobeng, AK
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (08) : 840 - 844
  • [2] Aromataris E, 2014, AM J NURS, V114, P53, DOI 10.1097/01.NAJ.0000444496.24228.2c
  • [3] Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
  • [4] The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
    Barker, Timothy Hugh
    Stone, Jennifer C.
    Sears, Kim
    Klugar, Miloslav
    Tufanaru, Catalin
    Leonardi-Bee, Jo
    Aromataris, Edoardo
    Munn, Zachary
    [J]. JBI EVIDENCE SYNTHESIS, 2023, 21 (03) : 494 - 506
  • [5] Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process
    Barker, Timothy Hugh
    Stone, Jennifer C.
    Sears, Kim
    Klugar, Miloslav
    Leonardi-Bee, Jo
    Tufanaru, Catalin
    Aromataris, Edoardo
    Munn, Zachary
    [J]. JBI EVIDENCE SYNTHESIS, 2023, 21 (03) : 478 - 493
  • [6] Quasi-experimental study designs series-paper 2: complementary approaches to advancing global health knowledge
    Geldsetzer, Pascal
    Fawzi, Wafaie
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 89 : 12 - 16
  • [7] JBI series paper 1: Introducing JBI and the JBI Model of EHBC
    Jordan, Zoe
    Lockwood, Craig
    Aromataris, Edoardo
    Pilla, Bianca
    Porritt, Kylie
    Klugar, Miloslav
    Riddle, Dru
    Wang, Ning
    Munn, Zachary
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 150 : 191 - 195
  • [8] Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.1136/bmj.l4898, 10.4084/MJHID.2010.005]
  • [9] What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences
    Munn, Zachary
    Stern, Cindy
    Aromataris, Edoardo
    Lockwood, Craig
    Jordan, Zoe
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2018, 18
  • [10] Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1016/j.ijsu.2021.105906, 10.1136/bmj.n71, 10.1136/bmj.n160]